Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Emanagers Total Index declines 1.07% in October (+3.33% YTD)

Thursday, November 22, 2012

amb
Florian Guldner, Opalesque Research:

Emerging manager hedge funds and managed futures funds generated losses last month, according to a first estimation based on the data of 298 funds listed in Opalesque Solutions' Emanagers database.

The Emanagers Total Index lost 1.07% in October, reducing its year-to-date performance to +3.33%. Estimates for September and August were corrected to +0.15% and +0.73%, respectively. Since inception in January 2009, the index posted compounded returns of 62%.

Over the last 12 months, emerging managers gained 2.82% in 7 negative and 5 positive months, compared to 2.87% for the Eurekahedge Hedge Fund Index. Global stocks, tracked by the MSCI World Index, gained approximately 10% in the same period.

Managed futures strategies had their worst month so far this year, while hedge funds experienced only small losses: The Emanagers Hedge Fund Index lost 0.21% (+5.84% YTD), while the Emanagers CTA Index lost 2.14% (-1.98% YTD).

The month of October proved to be a difficult macro environment with declining commodity prices, and changing directional movements of interest rates and equity prices. As a result, most investment strategies came under pressure:

  • Relative value and equity long-bias strategies performed best, with gains of 1.57% and 1.36%. Global macro hedge funds did slightly bet......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its